We are live on ! Find out more
SAM

Senzar Asset Management Portfolio holdings

AUM $34.7M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
-1.15%
1 Year Est. Return
+0.56%
3 Year Est. Return
-0.75%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$34.7M
AUM Growth
-$282M
Cap. Flow
-$283M
Cap. Flow %
-815.27%
Top 10 Hldgs %
75.76%
Holding
38
New
7
Increased
–
Reduced
18
Closed
13

Top Buys

Rank Stock Value
1
RDUS
Radius Health, Inc.
RDUS
+$1.91M
2
GILD icon
Gilead Sciences
GILD
+$1.57M
3
MCK icon
McKesson
MCK
+$1.1M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$538K
5
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
+$347K

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$24.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$17.7M
3
SNY icon
Sanofi
SNY
+$17.1M
4
VTRS icon
Viatris
VTRS
+$16.1M
5
PFE icon
Pfizer
PFE
+$15.5M

Sector Composition

Rank Sector Weight
1 Healthcare 91.91%
2 Financials 0%

No holdings matched the selected filter criteria.

1 2

Similar funds

BCP
Blum Capital Partners San Francisco, California $34.1M AUM 1.14% 1-Year Est. Return
PRHC
P.R. Herzig & Co Roslyn Heights, New York $45.9M AUM 15.88% 1-Year Est. Return
NAM
Needelman Asset Management Ladera Ranch, California $46M AUM 8.27% 1-Year Est. Return
GG
Gores Group Beverly Hills, California $22.3M AUM 4.58% 1-Year Est. Return
SM
SLS Management New York $17.2M AUM 14.82% 1-Year Est. Return
BC
Breogan Capital New York $56.4M AUM
SCPM
Social Capital PEP Management Palo Alto, California $56.5M AUM
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return

Senzar Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Senzar Asset Management held 38 positions worth $34.7M, down 89% from $317M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Senzar Asset Management withdrew a net $283M in Q2 2018, closing 13 positions and reducing 18 holdings. Its most notable exit was Pfizer, an estimated $15.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 86% a quarter earlier, followed by Financials.

Against the trend, Senzar Asset Management opened a new position in Radius Health, Inc. worth $1.78M.

  • Senzar Asset Management's largest Q2 2018 buy was Radius Health, Inc.: 60,521 shares worth $1.78M.
  • Senzar Asset Management's biggest Q2 2018 reduction was AstraZeneca, cutting an estimated $24.7M.
  • Senzar Asset Management fully exited Pfizer in Q2 2018, selling an estimated $15.5M.
  • Senzar Asset Management's ten largest holdings make up 76% of its $34.7M portfolio in Q2 2018.
  • Senzar Asset Management opened 7 new positions and closed 13 in Q2 2018.
  • Senzar Asset Management's portfolio value fell 89% quarter-over-quarter to $34.7M.

Based on Senzar Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.